GUJARAT INJECT (KERALA) LTD.

Gujarat Inject Kerala Ltd has announced Thursday, July 2, 2026, as the Record Date for its upcoming stock split. The company's Board of Directors approved the sub-division of equity shares, where each existing equity share with a face value of ₹10 will be split into 10 equity shares of Re.1 each. This corporate action, aimed at increasing liquidity and affordability of shares, has received approval from shareholders via an Ordinary Resolution at an Extra-Ordinary General Meeting. The split ratio is 1:10, changing the face value from ₹10 to Re.1 per share.

Gujarat Inject Kerala Limited (soon to be Regenova Renewtech Limited) has secured a purchase order worth approximately ₹14.49 crore (excluding GST) from Deon Energy Limited for 16,129 Solar PV Modules of 620 WP capacity. This order strengthens the company's position in the renewable energy sector and follows a period of strong financial performance, with FY26 revenue growing 91% YoY to ₹36.32 crore and net profit increasing 78% YoY to ₹1.81 crore. The company also reported a significant surge in Q4FY26 revenue to ₹30.70 crore from ₹4.24 crore in Q4FY25. The rebranding to Regenova Renewtech Limited reflects its strategic focus on renewable energy.

Gujarat Inject Kerala Ltd has secured a significant purchase order from DEON ENERGY LIMITED for 16,129 Solar PV Modules. The total value of this order is approximately ₹14.49 Crores, excluding GST. The modules are expected to be delivered by June 2026. This order represents a substantial business win for the company in the renewable energy sector.

Gujarat Inject Kerala Ltd has secured a purchase order from OTTRIVE LIFESTYLE PRIVATE LIMITED for 1334 Solar PV Modules. The total value of the order is approximately ₹1.07 Crores, excluding GST. The order is expected to be executed by June 2026. This contract represents a significant business win for the company in the renewable energy sector.

Gujarat Inject Kerala Ltd, soon to be REGENOVA RENEWTECH LIMITED, announced strong FY26 results with a 91% YoY revenue increase to ₹36.32 crore and a 78% YoY net profit rise to ₹1.81 crore. Q4FY26 revenue surged sevenfold to ₹30.70 crore, with net profit jumping to ₹1.64 crore. The company secured multiple solar PV module orders, including from Earthwave Technology, Perfect Renewtech, and Surja Infra, totaling ₹14.5 crore. The company is expanding into renewable energy and solar solutions, including a 5MW solar project in Gujarat.

Gujarat Inject Kerala Ltd's Board of Directors approved the audited standalone financial results for the fourth quarter and year ended March 31, 2026, in a meeting held on May 20, 2026. The audit report, issued by M/s. S. Mandawat & Co., Statutory Auditors, contained an unmodified opinion. The board meeting commenced at 5:10 P.M and concluded at 5:55 P.M.

Gujarat Inject Kerala Ltd approved audited standalone financial results for the fourth quarter and year ended March 31, 2026, in a board meeting held on May 20, 2026. The board also took on record the audit report issued by M/s. S. Mandawat & Co., Statutory Auditors, with an unmodified opinion on the statement. The audit firm, S. MANDAWAT & CO., conducted the audit in accordance with the Standards on Auditing and issued an independent Auditor's Report with an unmodified opinion.

Mr. Murli Shivshankaran Nair resigned from the position of Managing Director and Chairman of Gujarat Inject Kerala Ltd, effective May 16, 2026. Mr. Deepak Diwan Bachwani has been appointed as Whole Time Director and designated as Chairman, also effective May 16, 2026, subject to member approval. Mr. Nair's resignation letter, citing personal commitments, has been accepted, and he is relieved of his duties immediately.

Gujarat Inject Kerala Ltd announced the appointment of Mr. Deepak Diwan Bachwani as Whole Time Director and Chairman, effective May 16, 2026, succeeding Mr. Murli Shivshankaran Nair, who resigned from the same positions on the same date. Mr. Bachwani's appointment is subject to member approval. Mr. Nair cited personal commitments for his resignation.

Gujarat Inject Kerala Ltd has scheduled a Board of Directors meeting on May 20, 2026, to consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026, along with the Statutory Auditors' report. The meeting will also address any other business with the Chair's permission.